LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Gross margin 2016–2025
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) gross margin by fiscal year — reported gross profit divided by reported revenue.
31.3%FY2025 · since FY2016: 14.0% → 31.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 31.3% | -1.4 pp |
| FY2024 | 32.6% | +5.5 pp |
| FY2023 | 27.1% | -8.0 pp |
| FY2022 | 35.1% | -3.5 pp |
| FY2021 | 38.6% | +14.0 pp |
| FY2020 | 24.6% | +10.1 pp |
| FY2019 | 14.5% | -0.4 pp |
| FY2018 | 14.9% | -1.9 pp |
| FY2017 | 16.9% | +2.9 pp |
| FY2016 | 14.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LFCR financial trends
LFCR RevenueLFCR Net incomeLFCR Net marginLFCR Gross profitLFCR Operating incomeLFCR Operating marginLFCR Operating cash flowLFCR Free cash flowLFCR Capital expendituresLFCR Return on equityLFCR Stock buybacksLFCR Dividends paidLFCR Total assetsLFCR Total liabilitiesLFCR Shareholders’ equityLFCR overview →